Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Action: stop dosing, observe at home for 4 hours, resume next scheduled dose
small human dermatology studies report increases in collagen synthesis and reductions in wrinkle depth over 812 weeks. Phase 1: Activation (Weeks 14) Dose: 3.2 mg daily GHK-Cu activates collagen production while its copper component enables proper structural cross-linking BPC-157 builds the network of small blood vessels needed to feed active tissue TB-4 mobilizes and organizes repair cells KPV simultaneously suppresses inflammatory interference Expected: Skin hydration improves, tone evens, texture softens, redness decreases
AOD-9604 5 mg | Research Use Only This listing provides a 5 mg vial of AOD-9604 for cell-based and biochemical model systems
Drug Interactions: No significant drug interactions with AOD-9604 have been documented in clinical research
